Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC38
TNBC
Basal B
MG-132
Proteasome
Proteasome
10578.145
uM
0.2760
0.45953
-0.9775 -0.9583 2.0996 0.7930
0.9951
1.6766
HCC38
TNBC
Basal B
MG-132
Proteasome
Proteasome
14616.189
uM
0.24510
0.33574
-0.9777 -0.9730 3.4335 0.8398
0.9968
1.4258
HCC38
TNBC
Basal B
MG-132
Proteasome
Proteasome
14616.189
uM
0.24510
0.33574
-0.9777 -0.9730 3.4335 0.8398
0.9968
1.4258
HCC38
TNBC
Basal B
MG-132
Proteasome
Proteasome
11850.145
uM
0.18684
0.24135
-0.7584 -0.7476 3.5716 0.7743
0.9991
2.1492
HCC38
TNBC
Basal B
MG-132
Proteasome
Proteasome
11850.145
uM
0.18684
0.24135
-0.7584 -0.7476 3.5716 0.7743
0.9991
2.1492
HCC38
TNBC
Basal B
Pevonedistat
NAE1
NAE1
10578.135
uM
0.10019
0.18239
-0.5216 -0.5061 1.1672 0.7151
0.9903
1.7650
HCC38
TNBC
Basal B
Pevonedistat
NAE1
NAE1
11850.135
uM
0.02928
0.05418
-0.6865 -0.6534 1.3585 0.9345
0.9941
1.9060
HCC38
TNBC
Basal B
Nelfinavir
12617.174
uM
13.99550
18.38860
-0.5913 -0.7927 3.4795 0.1133
0.9986
1.5935
HCC38
TNBC
Basal B
Nilotinib
ABL
nRTK
11850.145
uM
inf
inf
1.0500 1.0500 0.0000 0.0017
-0.0001
2.1492
HCC38
TNBC
Basal B
Nilotinib
ABL
nRTK
10578.145
uM
74.17850
26.03660
0.4519 0.4436 2.0847 0.1179
0.9504
1.6766
HCC38
TNBC
Basal B
NSC 663284
CDC25
CDC
10578.14
uM
2.19560
3.93220
-0.9845 -0.9440 1.8201 0.5926
0.9961
1.6718
HCC38
TNBC
Basal B
NSC 663284
CDC25
CDC
11850.159
uM
2.33660
4.17950
-0.8493 -0.8515 1.7100 0.5567
0.9968
1.9270
HCC38
TNBC
Basal B
NU6102
CDK1/2
CDK
11850.147
uM
11.04560
23.12730
-0.6760 -1.0000 1.4867 0.2513
0.9804
2.1087
HCC38
TNBC
Basal B
Nutlin 3a
MDM2
MDM2
10418.066
uM
20.57240
58.9080
-0.0794 -1.0000 1.0443 0.1536
0.9555
1.1532
HCC38
TNBC
Basal B
Nutlin 3a
MDM2
MDM2
7468.066
uM
19.68030
34.18440
-0.5845 -1.0000 1.9897 0.1867
0.9778
1.3940
HCC38
TNBC
Basal B
Nutlin 3a
MDM2
MDM2
7469.066
uM
22.40
21.64890
0.0801 0.0762 4.8483 0.0758
0.9892
2.0057
HCC38
TNBC
Basal B
Olomoucine II
CDK1
CDK
11850.147
uM
3.35060
5.31960
-0.5182 -0.5635 1.6326 0.4202
0.9947
2.1087
HCC38
TNBC
Basal B
Omipalisib
PI3K
PI3K
10418.087
uM
0.02066
0.08380
-0.8268 -0.8232 0.6949 0.8703
0.9860
1.1498
HCC38
TNBC
Basal B
Omipalisib
PI3K
PI3K
10578.087
uM
0.05466
0.14499
-0.8799 -0.8177 0.9932 0.7587
0.9953
1.3188
HCC38
TNBC
Basal B
Omipalisib
PI3K
PI3K
7468.086
uM
0.02614
0.07378
-0.7918 -0.7776 0.9042 0.8412
0.9990
1.2962
HCC38
TNBC
Basal B
Oxaliplatin
DNA cross-linker
DNA cross-linker
10268.12
uM
inf
inf
-1.0000 -1.0000 0.0000 1.2668
0.5308
0.3272
HCC38
TNBC
Basal B
Oxaliplatin
DNA cross-linker
DNA cross-linker
9028.075
uM
1.74280
5.86920
-0.9728 -1.0000 0.9048 0.7022
0.9921
0.6011
HCC38
TNBC
Basal B
Oxaliplatin
DNA cross-linker
DNA cross-linker
9469.011
uM
4.17480
16.25840
-0.9375 -1.0000 0.8081 0.5798
0.9953
1.1991
HCC38
TNBC
Basal B
Oxaliplatin
DNA cross-linker
DNA cross-linker
9453.011
uM
7.91820
17.01960
-0.9837 -1.0000 1.4357 0.5359
0.9966
0.7773
HCC38
TNBC
Basal B
Oxamflatin
HDAC
HDAC
11850.147
uM
0.19648
0.41806
-0.7791 -0.7901 1.2553 0.7279
0.9960
2.1087